Luxembourg vs Mus: Previously treated cases tested for RR-/MDR-TB (%)
Luxembourg
100.0%
in 2024
Mus
100.0%
in 2022
Luxembourg rank
1st
Mus rank
1st
Previously treated cases tested for RR-/MDR-TB (%) over time
- Luxembourg
- Mus
How they compare
Luxembourg currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
Across all 5 years both countries report, Mus has been ahead every year.
Luxembourg ranks 1st and Mus ranks 1st of 180 countries.
Head to head by decade
| Decade | Luxembourg | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Luxembourg or Mus?
- Luxembourg, at 100.0% against 100.0% in Mus as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Luxembourg and Mus?
- 0.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Mus?
- 5 years are reported by both, from 2011 to 2022.
- How do Luxembourg and Mus rank globally for previously treated cases tested for rr-/mdr-tb?
- Luxembourg ranks 1st and Mus ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.